Dr. Roozbeh Sharif, M.D., M.ED., M.SC.
What this data tells you about Dr. Sharif
Dr. Roozbeh Sharif is an internal medicine specialist in Nederland, TX, with 14 years of NPI registration. Based on federal Medicare data, Dr. Sharif performed 5,626 Medicare services across 2,103 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sharif received a total of $13,611 from 27 pharmaceutical and/or device companies across 221 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sharif is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | 1,199 | $113 | $325 |
| Office visit, established patient, complex (40-54 min) | 722 | $131 | $400 |
| Critical care, first 30-74 min | 344 | $162 | $700 |
| Test to measure rate of airflow | 315 | $28 | $89 |
| Test to examine how well the lungs exchange gases | 291 | $42 | $135 |
| Test to determine lung volumes using sensors | 290 | $40 | $127 |
| Test for exercise-induced lung stress | 263 | $25 | $80 |
| Hospital follow-up visit, high complexity | 239 | $88 | $310 |
| Nursing facility visit, moderate complexity | 180 | $80 | $250 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 177 | $26 | $100 |
| Test to measure lung function response to low oxygen | 177 | $60 | $159 |
| Test to measure lung airway sensitivity | 151 | $43 | $142 |
| Office visit, established patient (30-39 min) | 134 | $94 | $322 |
| Test to measure expiratory airflow and volume | 129 | $20 | $60 |
| Sleep study including heart rate, breathing, and sleep time | 121 | $107 | $364 |
| Hospital follow-up visit, moderate complexity | 108 | $58 | $210 |
| Nursing facility visit, low complexity | 108 | $56 | $180 |
| New patient office visit, complex (60-74 min) | 93 | $159 | $505 |
| Office visit, established patient (10-19 min) | 90 | $41 | $133 |
| Drug injection, under skin or into muscle | 76 | $11 | $35 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 56 | $54 | $183 |
| Telephone medical discussion with physician, 21-30 minutes | 46 | $91 | $290 |
| Office visit, established patient (20-29 min) | 45 | $68 | $215 |
| Blood draw (venipuncture) | 42 | $8 | $80 |
| Test for exercise-induced heart and lung stress | 41 | $114 | $385 |
| Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg | 38 | $0 | $44 |
| Inhalation treatment for airway obstruction or sputum production | 27 | $7 | $26 |
| Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 25 | $0 | $20 |
| Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | 21 | $133 | $426 |
| Initial hospital admission, high complexity | 20 | $127 | $456 |
| Hospital discharge management, 30+ min | 16 | $87 | $255 |
| Inhalation treatment for acute airway obstruction, first hour | 15 | $44 | $124 |
| Telephone medical discussion with physician, 11-20 minutes | 15 | $67 | $204 |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 12 | $0 | $50 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (56%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 7% for internal medicine in TX.
Geographic Context
8.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Sharif is a clinical cardiology specialist, with above-average Medicare volume (top 6% in TX), with consulting-driven industry engagement in the top 7% of TX peers.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Sharif experienced with subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes?
Does Dr. Sharif receive payments from pharmaceutical companies?
How do Dr. Sharif's costs compare to other internal medicine physicians in Nederland?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology